Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire

被引:33
|
作者
Burrows, SR
Silins, SL
Cross, SM
Peh, CA
Rischmueller, M
Burrows, JM
Elliott, LS
McCluskey, J
机构
[1] FLINDERS MED CTR,DEPT CLIN IMMUNOL,BEDFORD PK,SA 5042,AUSTRALIA
[2] AUSTRALIAN RED CROSS SOC,SA DIV,BLOOD TRANSFUS SERV,ADELAIDE,SA,AUSTRALIA
关键词
cytotoxic T lymphocyte; tolerance; HLA; repertoire development;
D O I
10.1002/eji.1830270126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The memory response to the immunodominant Epstein-Barr virus (EBV) epitope FLRGRAYGL, which associates with HLA B8, is exceptionally restricted, being dominated by cytotoxic T lymphocytes (CTL) with a single, public T cell receptor (TCR). CTL clones that express this receptor fortuitously cross-react with the alloantigen HLA B44. However, of the two major subtypes of this HLA, B*4402 and B*4403, that differ by a single amino acid, only the former is recognized by these mature CTL clones. Individuals heterozygous for HLA EX and B*4402 use alternative TCR for the EBV determinant since the dominant TCR is potentially self-reactive. We now demonstrate that this clonotype is also essentially absent from the repertoire of CTL directed against the viral epitope in seven from seven unrelated individuals heterozygous for HLA B8 and B*440 (3) under bar. Thus immune tolerance of these CTL recognizing HLA B*4402 is associated with expression of either B*4402 or B*4403. This suggests that tolerance in the human T cell compartment requires a lower threshold of recognition than for effector function, thus providing a buffer zone minimizing the risk of autoimmunity. These data also illustrate the potential for non-restricting HLA molecules to bias dramatically the T cell repertoire used for specific immune responses. Such influences may be the basis of the ''protective'' effects of certain HLA alleles in susceptibility to autoimmune disorders.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 50 条
  • [31] Non-human leukocyte antigen-specific antibodies in thoracic transplantation
    Reinsmoen, Nancy L.
    Zhang, Xiaohai
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2016, 21 (04) : 350 - 354
  • [32] Soluble T-lymphocyte antigen-specific immunoproteins: A progress report
    Cone, RE
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 214 (03): : 204 - 209
  • [33] SELECTION AND ENRICHMENT OF ANTIGEN-SPECIFIC T-LYMPHOCYTE POPULATIONS - REVIEW
    BENSASSON, SZ
    PAUL, WE
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1976, 12 (4-5): : 414 - 424
  • [34] Lymphocyte trafficking and antigen-specific T cell proliferation in mouse aortas
    Galkina, E
    Varughese, D
    Harry, BL
    Ley, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E90 - E90
  • [35] 2 ROLES FOR IA IN ANTIGEN-SPECIFIC LYMPHOCYTE-T ACTIVATION
    KIM, KH
    SHIVDASANI, RA
    THOMAS, DW
    JOURNAL OF IMMUNOLOGY, 1986, 137 (11): : 3393 - 3400
  • [36] EFFECT OF PAMIDRONATE ON ANTIGEN-SPECIFIC AND NONSPECIFIC T-LYMPHOCYTE PROLIFERATION
    CELIS, L
    GEUSENS, P
    RAUS, J
    ZHANG, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S435 - S435
  • [37] Antigen-specific immune responsiveness and lymphocyte recruitment in leukocyte adhesion deficiency type II
    Kuijpers, TW
    Etzioni, A
    Pollack, S
    Pals, ST
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (04) : 607 - 613
  • [38] Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy
    Chi Zhang
    Yanchun Peng
    Philip Hublitz
    Haokang Zhang
    Tao Dong
    Scientific Reports, 8
  • [39] Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells
    Salio, M
    Dulphy, N
    Renneson, J
    Herbert, M
    McMichael, A
    Marchant, A
    Cerundolo, V
    INTERNATIONAL IMMUNOLOGY, 2003, 15 (10) : 1265 - 1273
  • [40] Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy
    Zhang, Chi
    Peng, Yanchun
    Hublitz, Philip
    Zhang, Haokang
    Dong, Tao
    SCIENTIFIC REPORTS, 2018, 8